Casdin Capital’s Definitive Healthcare DH Stock Holding History

Casdin Capital’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-360,000	Closed	-$3.96M	–	43
2022 Q4	$3.96M	Buy	+360,000	New	+$4.63M	0.31%	39

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Casdin Capital's DH Position: Q1 2023 in Review

Casdin Capital sold out of Definitive Healthcare (DH) in Q1 2023, closing a stake of 360,000 shares — an estimated $3.96M sold.

Casdin Capital first reported a position in DH in Q4 2022 and held it in 1 quarter. The position peaked at $3.96M in Q4 2022. 144 funds tracked by Wall St. Rank hold DH as of Q1 2023.

Casdin Capital reported no remaining Definitive Healthcare position as of Q1 2023 after selling out during the quarter.
Casdin Capital sold 360,000 Definitive Healthcare shares in Q1 2023, an estimated $3.96M.
Casdin Capital first reported a position in Definitive Healthcare in Q4 2022 and held it in 1 quarter.
Casdin Capital's Definitive Healthcare position peaked at $3.96M in Q4 2022.
144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2023.

Based on Casdin Capital's 13F filing for Q1 2023, filed 15 May 2023.